ALPHARETTA, Ga. and JOHN’S CREEK, Ga., July 21, 2016 /PRNewswire/ — Halyard Health, Inc. (NYSE: HYH), and Belintra today announced a co-marketing arrangement to offer sterilization packaging and logistics solutions. By combining Halyard Health’s clinically-superior sterilization wrap products with Belintra’s innovative storage and transport logistics flow system for wrapped surgical instrument trays, the two companies will provide effective, comprehensive solutions for fulfilling surgical instrument sterility and help to improve hospitals’ clinical efficiency.
“Halyard Health is continually working to identify opportunities to help our customers address challenges across healthcare delivery, including mitigating risks for healthcare-associated infections and readmissions,” said Alex Hodges, general manager Surgical and Infection Prevention, Halyard Health. “Our co-marketing arrangement with Belintra will provide our customers with customizable, uniquely superior solutions for reducing opportunities for surgical instrument contamination, helping to ensure that sterility is maintained post-sterilization through handling and transport to the operating room.”
To see this sterilization packaging and logistics solution click here.
Approximately 300,000 surgical site infections occur annually in U.S. hospitals, resulting in an estimated 9,000 attributable deaths.i,ii,iii Halyard’s state-of-the-art SMART-FOLD* and QUICK-CHECK* sterilization wraps provide industry-leading protection against contamination of surgical instruments. In a recent scientific study iv published in the American Journal of Infection Control, sterilization wrap was shown to maintain 100 percent sterility post-sterilization compared to rigid containers, of which 87 percent were positive for bacterial contamination post-sterilization.iv With this co-marketing arrangement, Halyard Health customers will be able to purchase transport solutions through Belintra, including Belintra’s Sterisystem™ Logistics Flow Solution, which helps organizations to adhere to AAMI Standard 79 guidelines and improve efficiencies with:
“While demands on central service departments are ever evolving, patient safety remains hospitals’ number one priority,” said Geert Schepens, CEO, Belintra. “We are pleased to have a promotion arrangement with Halyard Health to harness our collective capabilities to provide access to a one-of-a-kind solution that allows hospitals to benefit from the flexibility, cost and effectiveness of sterilization wrap with a more efficient means for storage and transportation of wrapped instrument trays post-sterilization.”
The Sterisystem™ Logistics Flow Solution will be promoted alongside Halyard Health’s full portfolio of sterilization wraps, representing a complete product portfolio for safeguarding instrument sterility, coupled with the dependable service and support Halyard Health customers have long relied on.
About Halyard Health
Halyard Health, Inc. (NYSE: HYH) is a medical technology company focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. Headquartered in Alpharetta, Georgia, Halyard is committed to addressing some of today’s most important healthcare needs, such as preventing healthcare-associated infections and reducing the use of narcotics while helping patients move from surgery to recovery. Halyard’s business segments – Surgical and Infection Prevention and Medical Devices – develop, manufacture and market clinically superior solutions that improve medical outcomes and business performance in more than 100 countries. For more information, visit www.halyardhealth.com.
Belintra NV, founded in 1965, is a leading provider of safe and smart healthcare logistics solutions with global headquarters in Belgium. For extensive company and product information, please visit www.belintra.com.
The US subsidiary Belintra, Inc. was founded in 2015. The US sales headquarters are located in Georgia and the warehouse in South Carolina. For US specific information, visit www.belintra.com/us.
Research was funded by Halyard Health, Inc. and conducted by Applied Research Associates, an international research laboratory. Halyard Health did not have any direct involvement in execution of the study. The study took place in an independent laboratory in Panama City, Florida, and the study was conducted by independent researchers.
i Anderson DJ, Kaye KS, Classen D, Arias KM, Podgorny K, Burstin H, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008 Oct;29 Suppl 1:S51-61.
ii Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003 Mar 1;36(5):592-98.
iii Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999 Nov;20(11):725-30.
iv Harry L. Shaffer MS†, Delbert A. Harnish MS†, Michael McDonald MS, Reid A. Vernon BS, Brian K. Heimbuch MS†. Sterility maintenance study: Dynamic evaluation of sterilized rigid containers and wrapped instrument trays to prevent bacterial ingress. Am J Infect Control. 2015 Dec;43(12)1336–1341.
† Harry L. Shaffer MS, Delbert A. Harnish MS, and Brian K. Heimbuch MS contributed to/authored the above article at the time they had a financial consulting relationship with Halyard Health, Inc.; however, they were not compensated by Halyard Health, Inc. for their respective contributions/authorship of the article.
SOURCE Halyard Health, Inc.